European All-comers' Multicentric Prospective REGISTRY on LUMINOR© Drug Eluting Balloon in the Superficial Femoral Artery and Popliteal Artery With 5 Years Follow-up.

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2026

Conditions
AngioplastyPeripheral Arterial DiseaseDrug-eluting BalloonFemoral ArteryPaclitaxel
Interventions
DEVICE

LUMINOR© Paclitaxel eluting balloon

Patients will be treated with the Luminor paclitaxel eluting balloon

Trial Locations (15)

13005

RECRUITING

CHU Timone Marseille, Marseille

29200

RECRUITING

Centre Hospitalier Régional Universitaire Morvan de Brest, Brest

30000

RECRUITING

Hôpital Privé des Franciscaines, Nîmes

33000

RECRUITING

Centre Hospitalier Universitaire Pellegrin, Bordeaux

33300

RECRUITING

Polyclinic Bordeaux Nord Aquitaine, Bordeaux

34430

RECRUITING

Clinique Saint Jean, Saint-Jean-de-Védas

40024

RECRUITING

CH Layné, Mont-de-Marsan

56100

RECRUITING

Clinic Mutualiste Porte de L'Orient, Lorient

59000

RECRUITING

CHRU Lille, Lille

64100

RECRUITING

Centre hospitalier de la Côte Basque, Bayonne

67000

RECRUITING

Clinique Rhéna, Strasbourg

74000

RECRUITING

Clinique Générale Annecy, Annecy

75014

RECRUITING

Fondation Hôpital St Joseph, Paris

84000

RECRUITING

Clinique Rhône Durance, Avignon

92100

RECRUITING

Hôpital Ambroise Paré, Boulogne-Billancourt

All Listed Sponsors
lead

iVascular S.L.U.

INDUSTRY